Cite
HARVARD Citation
Pan, S. et al. (n.d.). 2552 Real Life treatment sequences and survival of men with metastatic castrate-resistant prostate cancer (mCRPC) receiving cabazitaxel in UK clinical practice. European journal of cancer. pp. S493-S494. [Online].